13 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/6/26 16:57
3/4/26
BBIOHealthDrugPharmaceutical PreparationsEllis AndreaCAD4S.d-6,42452.620-12219D
3/3/26 16:17
2/27/26
BBIOHealthDrugPharmaceutical PreparationsValantine HannahCAD5S.d-4,20057.660-738D
2/27/26 16:11
2/26/26
BBIOHealthDrugPharmaceutical PreparationsApuli MaricelCAOChief Ac5S-40361.710-7148D
2/23/26 16:32
9/4/25
BBIOHealthDrugPharmaceutical PreparationsKumar NeilCADOCEO19S.dm-80,32246.280-1,7356,906I
2/18/26 18:36
2/17/26
BBIOHealthDrugPharmaceutical PreparationsTrimarchi ThomasCAOP,CFO4S-5,10356.630-90463D
2/18/26 18:34
2/17/26
BBIOHealthDrugPharmaceutical PreparationsScott Randal W.CAD2S.d-1,42171.050-2016D
11/19/25 17:08
11/17/25
BBIOHealthDrugPharmaceutical PreparationsLo AndrewCAD2S.m-10,17051.990-196154M
11/7/25 18:03
11/6/25
BBIOHealthDrugPharmaceutical PreparationsDaniels Ronald JCAD1S.d-3,88963.720-6117D
10/31/25 16:38
10/29/25
BBIOHealthDrugPharmaceutical PreparationsMcCormick FrankCAD4S.d-21,67057.940-374963I
8/12/25 19:06
8/8/25
BBIOHealthDrugPharmaceutical PreparationsHomcy Charles JCAD1S.m-13,91246.370-300917D
7/1/25 19:48
6/27/25
BBIOHealthDrugPharmaceutical PreparationsViking Global Investors LPCTT2S-260,99039.750-6,56622,055I
5/14/25 17:24
5/12/25
BBIOFinancInvAdvInvestment AdviceKkr Genetic Disorder L.P.NYT2S-402,96033.580-12,00019,261I
2/27/25 17:36
2/25/25
BBIOHealthDrugPharmaceutical PreparationsStephenson Brian CCAOCFO,Trea4S.d-2,99335.290-85102D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact